GB1539473A - N-aryl-n-(1-l-4-piperidinyl)-arylacetamides - Google Patents
N-aryl-n-(1-l-4-piperidinyl)-arylacetamidesInfo
- Publication number
- GB1539473A GB1539473A GB39099/76A GB3909976A GB1539473A GB 1539473 A GB1539473 A GB 1539473A GB 39099/76 A GB39099/76 A GB 39099/76A GB 3909976 A GB3909976 A GB 3909976A GB 1539473 A GB1539473 A GB 1539473A
- Authority
- GB
- United Kingdom
- Prior art keywords
- arylacetamides
- piperidinyl
- aryl
- formula
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61513175A | 1975-09-23 | 1975-09-23 | |
US71375676A | 1976-08-12 | 1976-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1539473A true GB1539473A (en) | 1979-01-31 |
Family
ID=27087421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB39099/76A Expired GB1539473A (en) | 1975-09-23 | 1976-09-21 | N-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS6016417B2 (cs) |
AT (1) | AT363935B (cs) |
AU (1) | AU510029B2 (cs) |
BG (1) | BG27543A3 (cs) |
CA (1) | CA1068271A (cs) |
CH (1) | CH628623A5 (cs) |
CS (1) | CS222663B2 (cs) |
DE (1) | DE2642856A1 (cs) |
DK (1) | DK150478C (cs) |
ES (1) | ES451768A1 (cs) |
FI (1) | FI61482C (cs) |
FR (1) | FR2325377A1 (cs) |
GB (1) | GB1539473A (cs) |
GR (1) | GR58469B (cs) |
HU (1) | HU172964B (cs) |
IE (1) | IE43802B1 (cs) |
IL (1) | IL50522A (cs) |
IT (1) | IT1073893B (cs) |
LU (1) | LU75837A1 (cs) |
NL (1) | NL187267C (cs) |
NO (1) | NO147672C (cs) |
NZ (1) | NZ181972A (cs) |
PH (1) | PH12497A (cs) |
PL (2) | PL192578A1 (cs) |
PT (1) | PT65631B (cs) |
RO (1) | RO70079A (cs) |
SE (1) | SE427839B (cs) |
SU (1) | SU747424A3 (cs) |
YU (1) | YU39973B (cs) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8791120B2 (en) | 2007-02-13 | 2014-07-29 | Janssen Pharmaceutica Nv | Fast-dissociating dopamine 2 receptor antagonists |
US8895562B2 (en) | 2008-07-31 | 2014-11-25 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
US8906921B2 (en) | 2007-04-23 | 2014-12-09 | Janssen Pharmaceutica Nv | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
US8933101B2 (en) | 2007-04-23 | 2015-01-13 | Janssen Pharmaceutica Nv | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
US8940743B2 (en) | 2005-10-26 | 2015-01-27 | Janssen Pharmaceutica Nv | Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
CN118496638A (zh) * | 2024-07-22 | 2024-08-16 | 海安浩驰科技有限公司 | 一种抗紫外车窗膜及其制备方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA765684B (en) * | 1975-09-23 | 1978-04-26 | Janssen Pharmaceutica Nv | Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
JPS62260786A (ja) * | 1986-05-08 | 1987-11-13 | 株式会社ヘキトク | 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置 |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
JP2010525013A (ja) * | 2007-04-23 | 2010-07-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体 |
EP2310374B1 (en) | 2008-07-03 | 2012-10-31 | Janssen Pharmaceutica N.V. | Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
-
1976
- 1976-09-06 NO NO763054A patent/NO147672C/no unknown
- 1976-09-08 NZ NZ181972A patent/NZ181972A/xx unknown
- 1976-09-16 FR FR7627870A patent/FR2325377A1/fr active Granted
- 1976-09-17 AU AU17878/76A patent/AU510029B2/en not_active Expired
- 1976-09-20 CA CA261,551A patent/CA1068271A/en not_active Expired
- 1976-09-20 LU LU75837A patent/LU75837A1/xx unknown
- 1976-09-20 RO RO7687590A patent/RO70079A/ro unknown
- 1976-09-21 IT IT51370/76A patent/IT1073893B/it active
- 1976-09-21 CH CH1194876A patent/CH628623A5/de not_active IP Right Cessation
- 1976-09-21 GR GR51742A patent/GR58469B/el unknown
- 1976-09-21 IL IL50522A patent/IL50522A/xx unknown
- 1976-09-21 GB GB39099/76A patent/GB1539473A/en not_active Expired
- 1976-09-21 JP JP51112527A patent/JPS6016417B2/ja not_active Expired
- 1976-09-22 SE SE7610501A patent/SE427839B/xx not_active IP Right Cessation
- 1976-09-22 AT AT0702976A patent/AT363935B/de not_active IP Right Cessation
- 1976-09-22 PL PL19257876A patent/PL192578A1/xx not_active IP Right Cessation
- 1976-09-22 CS CS766139A patent/CS222663B2/cs unknown
- 1976-09-22 YU YU2336/76A patent/YU39973B/xx unknown
- 1976-09-22 HU HU76JA00000767A patent/HU172964B/hu not_active IP Right Cessation
- 1976-09-22 PL PL1976216213A patent/PL117323B1/pl unknown
- 1976-09-22 PT PT65631A patent/PT65631B/pt unknown
- 1976-09-22 DK DK427876A patent/DK150478C/da active
- 1976-09-22 FI FI762698A patent/FI61482C/fi not_active IP Right Cessation
- 1976-09-22 ES ES451768A patent/ES451768A1/es not_active Expired
- 1976-09-22 IE IE2095/76A patent/IE43802B1/en unknown
- 1976-09-22 NL NLAANVRAGE7610513,A patent/NL187267C/xx not_active IP Right Cessation
- 1976-09-22 PH PH18928A patent/PH12497A/en unknown
- 1976-09-23 DE DE19762642856 patent/DE2642856A1/de active Granted
- 1976-09-23 SU SU762405548A patent/SU747424A3/ru active
- 1976-09-23 BG BG034265A patent/BG27543A3/xx unknown
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8940743B2 (en) | 2005-10-26 | 2015-01-27 | Janssen Pharmaceutica Nv | Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
US9468640B2 (en) | 2005-10-26 | 2016-10-18 | Janssen Pharmaceutica Nv | Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
US9751860B2 (en) | 2005-10-26 | 2017-09-05 | Janssen Pharmaceutica Nv | Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
US8791120B2 (en) | 2007-02-13 | 2014-07-29 | Janssen Pharmaceutica Nv | Fast-dissociating dopamine 2 receptor antagonists |
US9422296B2 (en) | 2007-02-13 | 2016-08-23 | Janssen Pharmaceutica Nv | Fast-dissociating dopamine 2 receptor antagonists |
US8906921B2 (en) | 2007-04-23 | 2014-12-09 | Janssen Pharmaceutica Nv | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
US8933101B2 (en) | 2007-04-23 | 2015-01-13 | Janssen Pharmaceutica Nv | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
US8895562B2 (en) | 2008-07-31 | 2014-11-25 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
CN118496638A (zh) * | 2024-07-22 | 2024-08-16 | 海安浩驰科技有限公司 | 一种抗紫外车窗膜及其制备方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE434049B (sv) | Forfarande for framstellning av 1,4-dihydropyridinderivat | |
SE416298B (sv) | Forfarande for framstellning av nya bensimidazolinon derivat | |
GB1539473A (en) | N-aryl-n-(1-l-4-piperidinyl)-arylacetamides | |
GB1542514A (en) | 1-(benzazolylalkyl)piperidine derivatives | |
SE7514271L (sv) | Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat | |
SE7604476L (sv) | Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar | |
GB1492528A (en) | Pyrazinyl piperazine derivatives | |
ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
SE7411243L (cs) | ||
SE7811455L (sv) | 2-imino-imidazolidin-derivat | |
DD138321A5 (de) | Verfahren zur herstellung von trans-2-substituierten-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu-indolinderivaten | |
GB1471847A (en) | Dibenzofuran derivatives | |
AU505719B2 (en) | 4-(3-alkylaminopropoxy)-indole derivatives | |
ES414955A1 (es) | Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles. | |
SU674671A3 (ru) | Способ получени производных пирролидина | |
SE7508793L (sv) | Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav | |
CH611602A5 (en) | Process for the preparation of (N-ethyl-2-pyrrolidino)methylamine derivatives | |
SE7612961L (sv) | Tienamycinderivat | |
SE425248B (sv) | Forfarande for framstellning ac derivat av 4-tia-2,6-diaza(3.2.0)-2-hepten-oner | |
ES454280A1 (es) | Procedimiento para preparar 1-(2-(beta-naftiloxi)-etil)-3-metilpirazolona-(5). | |
ES410934A1 (es) | Procedimiento para la preparacion de acidos indolcarboxili-cos. | |
ES398080A1 (es) | Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina. | |
FR2315932A1 (fr) | Derives d'acides quinoleine-carboxyliques et medicaments qui en contiennent | |
SE412907B (sv) | Forfarande for framstellning av nya n-2'-karboxifenyl-4-klorantranilsyror | |
ES439180A1 (es) | Procedimiento para la preparacion de derivados de piperido- na. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |